Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
Tuesday, November 29, 2016
Vigene Biosciences, a biotechnology company focused on viral vector production and development, has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia's cGMP facility and equipment. The ...
read more
Wednesday, October 21, 2020
Vifor and Cara announced both companies have signed a license agreement for commercialization of Korsuva (difelikefalin) Injection.
read more
Thursday, December 16, 2021
Vifor Pharma Group announced the divestment of its finished drug product manufacturing business to CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) of APIs, Excipients, Drug Products, and associated Packaging ...
read more
Thursday, November 21, 2013
The Vietnam Ministry of Health’s Administration of Science, Technology and Training (ASTT) has signed an agreement with Quintiles to enhance clinical research in this rapidly growing nation of 90 million people, Quintiles announced today.
read more
Vibalogics will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical Companies of Johnson & Johnson.
read more
Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line for its specialist oncolytic virus and viral vector manufacturing services.
read more
Friday, September 02, 2016
Germany-based Vibalogics has expanded its capabilities with a new automatic vial filling line to meet increased demand from biotechnology companies for its specialist live biological manufacturing services for human and veterinary vaccines, gene ...
read more
Monday, November 23, 2020
Vibalogics has initiated Phase I of its planned $150m investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, Massachusetts.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Cryoport, Inc. and VGXI, Inc., announced a strategic partnership to support biopharmaceutical companies in developing cell and gene therapies and mRNA-based treatments.
read more
VGXI, Inc., a contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines and National Resilience, Inc. (Resilience), a technology-focused biomanufacturing ...
read more
Under a license agreement with the HMRI for development of clinical grade RNA manufacturing services, VGXI announced it has completed all of the partnership’s Phase I initiatives and anticipates Phase II will conclude by 4Q 2019.
read more
Wednesday, December 14, 2016
Vetter has announced that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials. The line is part of growth expansion activities that have been undertaken at its ...
read more
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.
read more